Latest Capital Raising News

iCandy Interactive is exploring a US listing for its subsidiary Lemon Sky Studios to unlock shareholder value, while facing a likely ASX delisting due to audit delays. The company also plans a capital raise to support these initiatives.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Caspin Resources has raised $6 million through an oversubscribed equity placement to fast-track exploration at its Bygoo Tin Project, focusing on expanding resources at the Kelpie Deposit and regional targets.

Cygnus Metals has successfully raised A$25 million through a well-supported placement to fund resource expansion and technical studies at its Chibougamau Copper-Gold Project in Canada.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

ADX Energy has secured A$4.4 million through a well-supported placement to fund key exploration projects in Austria and Italy, alongside plans for a strategic dual listing on Oslo Børs’ Euronext Growth market.

TZ Limited has completed a A$1.5 million capital raise at a premium, appointed David Sampaklis as Group CEO with significant shareholding, and repaid A$1 million of debt, positioning itself for growth in data centre security.

ActivEX Limited has completed a $421,752 share placement, issuing over 21 million shares at 2 cents each, to fund its exploration projects and support working capital. The shares are locked in escrow for 12 months, signaling a strategic move to strengthen its financial footing.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

Evolution Energy Minerals has successfully closed an oversubscribed $4 million rights issue, supplemented by a $150,000 follow-on placement, bolstering funds for key exploration and development projects.

ActivEX Limited has secured $421,753 through a placement of over 21 million shares at a slight discount, locking in investors for 12 months. The funds aim to boost exploration projects and shore up working capital.